receptor

(redirected from T-cell receptor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: receiver
Mentioned in ?
References in periodicals archive ?
Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline.
A monoclonal T-cell receptor band was observed from fresh tissue.
The T-cell receptor was engineered to bind to cancerous cells with a 30,000-fold improved affinity using technology developed by partners, Immunocore.
The same T-cell receptor also binds to molecules on other cells of the immune system as part of the systemwide activation process.
Well-illustrated with line drawings and clinical photographs, the topics include the barriers of the innate immune system to infection, pattern recognition molecules, phagocytes, interferons and other danger signals, the T-cell receptor and the generation of diversity, macromolecular antigen, immunoglobulin structure and classes, B cells and memory B cells, the secondary lymphoid organs, Type 1 to Type 4 hypersensitivity, tuberculosis, autoimmunity, tumors, vaccines and HIV.
After T-cell receptor stimulation, most patients also experience a decrease in the production of interleukins, possibly because of a defect in the signal transduction system of CD4 T cells.
If scientists can understand how T-cell receptor genes are switched on and off, and what they direct the immune system to do, they eventually may be able to halt such diseases.
This has resulted in the introduction of new technologies such as DNA vaccine preparation, T-cell receptor peptide vaccine preparation, recombinant vector vaccine preparation, and immunogenic inactivated cell culture vaccine preparation.
Today GSK announced that it has exercised the option to obtain an exclusive global license from Adaptimmune for an investigational SPEAR T-cell receptor therapy targeting NY-ESO-1 (GSK3377794).
will develop both autologous and allogenic ACT approaches by capitalizing on MD Anderson's world-leading clinical oncology and cell therapy expertise and Immatics' unrivaled cancer target and T-cell receptor (TCR) discovery capabilities.
Most cases are of [gamma]/[delta] T-cell origin, with a few expressing [alpha]/[beta] T-cell receptor.
Jakobsen said that they use scaffold of the T-cell receptor to make something that is very good at recognising cancer even if it doesn't exist naturally.

Full browser ?